• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NPORT-P filed by abrdn Healthcare Opportunities Fund Shares of Beneficial Inter

    2/29/24 12:37:38 PM ET
    $THQ
    Finance Companies
    Finance
    Get the next $THQ alert in real time by email
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM NPORT-P
    Monthly Portfolio Investments Report

    NPORT-P: Filer Information

    Filer CIK
    0001604522 
    Filer CCC
    ********  
    Filer Investment Company Type
     
    Is this a LIVE or TEST Filing? live is not checked LIVE test is not checked TEST
    Would you like a Return Copy? return copy flag is not checked
    Is this an electronic copy of an official filing submitted in paper format? Confirm flag is not checked

    Submission Contact Information

    Name
     
    Phone
     
    E-Mail Address
     

    Notification Information

    Notify via Filing Website only?Override internet flag is not checked
    Series ID
     

    NPORT-P: Part A: General Information

    Item A.1. Information about the Registrant.

    a. Name of Registrant
    abrdn Healthcare Opportunities Fund 
    b. Investment Company Act file number for Registrant: (e.g., 811-______)
    811-22955 
    c. CIK number of Registrant
    0001604522 
    d. LEI of Registrant
    549300WT8EMZSV1XVW72 

    e. Address and telephone number of Registrant.
    Street Address 1
    1900 Market Street 
    Street Address 2
    Suite 200 
    City
    PHILADELPHIA 
    State, if applicable
    PENNSYLVANIA  
    Foreign country, if applicable
    UNITED STATES OF AMERICA  
    Zip / Postal Code
    19103 
    Telephone number
    617-772-8500 

    Item A.2. Information about the Series.

    a. Name of Series.
    abrdn Healthcare Opportunities Fund 
    b. EDGAR series identifier (if any).
     
    c. LEI of Series.
    549300WT8EMZSV1XVW72 

    Item A.3. Reporting period.

    a. Date of fiscal year-end.
    2024-09-30 
    b. Date as of which information is reported.
    2023-12-31 

    Item A.4. Final filing

    Does the Fund anticipate that this will be its final filing on Form N PORT?Yes is not checked Yes No is checked No

    NPORT-P: Part B: Information About the Fund

    Report the following information for the Fund and its consolidated subsidiaries.

    Item B.1. Assets and liabilities. Report amounts in U.S. dollars.

    a. Total assets, including assets attributable to miscellaneous securities reported in Part D.
    1112018224.04 
    b. Total liabilities.
    235149612.84 
    c. Net assets.
    876868611.20 

    Item B.2. Certain assets and liabilities. Report amounts in U.S. dollars.

    a. Assets attributable to miscellaneous securities reported in Part D.
    0.00000000 
    b. Assets invested in a Controlled Foreign Corporation for the purpose of investing in certain types of instruments such as, but not limited to, commodities.
    0.00000000 

    c. Borrowings attributable to amounts payable for notes payable, bonds, and similar debt, as reported pursuant to rule 6-04(13)(a) of Regulation S-X [17 CFR 210.6-04(13)(a)].

    Amounts payable within one year.
    Banks or other financial institutions for borrowings.
    0.00000000 
    Controlled companies.
    0.00000000 
    Other affiliates.
    0.00000000 
    Others.
    0.00000000 
    Amounts payable after one year.
    Banks or other financial institutions for borrowings.
    225000000.00000000 
    Controlled companies.
    0.00000000 
    Other affiliates.
    0.00000000 
    Others.
    0.00000000 

    d. Payables for investments purchased either (i) on a delayed delivery, when-issued, or other firm commitment basis, or (ii) on a standby commitment basis.

    (i) On a delayed delivery, when-issued, or other firm commitment basis:
    0.00000000 
    (ii) On a standby commitment basis:
    0.00000000 
    e. Liquidation preference of outstanding preferred stock issued by the Fund.
    0.00000000 
    f. Cash and cash equivalents not reported in Parts C and D.
    0.00000000 

    Item B.3. Portfolio level risk metrics.

    If the average value of the Fund's debt securities positions for the previous three months, in the aggregate, exceeds 25% or more of the Fund's net asset value, provide:

    c. Credit Spread Risk (SDV01, CR01 or CS01). Provide the change in value of the portfolio resulting from a 1 basis point change in credit spreads where the shift is applied to the option adjusted spread, aggregated by investment grade and non-investment grade exposures, for each of the following maturities: 3 month, 1 year, 5 years, 10 years, and 30 years.

    Investment grade.
    Maturity period.
    3 month.
     
    1 year.
     
    5 years.
     
    10 years.
     
    30 years.
     
    Non-Investment grade.
    Maturity period.
    3 month.
     
    1 year.
     
    5 years.
     
    10 years.
     
    30 years.
     

    For purposes of Item B.3., calculate value as the sum of the absolute values of:
    (i) the value of each debt security,
    (ii) the notional value of each swap, including, but not limited to, total return swaps, interest rate swaps, and credit default swaps, for which the underlying reference asset or assets are debt securities or an interest rate;
    (iii) the notional value of each futures contract for which the underlying reference asset or assets are debt securities or an interest rate; and
    (iv) the delta-adjusted notional value of any option for which the underlying reference asset is an asset described in clause (i),(ii), or (iii).

    Report zero for maturities to which the Fund has no exposure. For exposures that fall between any of the listed maturities in (a) and (b), use linear interpolation to approximate exposure to each maturity listed above. For exposures outside of the range of maturities listed above, include those exposures in the nearest maturity.


    Item B.4. Securities lending.

    a. For each borrower in any securities lending transaction, provide the following information:

    b. Did any securities lending counterparty provide any non-cash collateral? Radio button not checked Yes Radio button checked No

    Item B.5. Return information.

    a. Monthly total returns of the Fund for each of the preceding three months. If the Fund is a Multiple Class Fund, report returns for each class. Such returns shall be calculated in accordance with the methodologies outlined in Item 26(b) (1) of Form N-1A, Instruction 13 to sub-Item 1 of Item 4 of Form N-2, or Item 26(b) (i) of Form N-3, as applicable.

    Monthly Total Return Record: 1
    Monthly total returns of the Fund for each of the preceding three months – Month 1.
    -7.11000000 
    Monthly total returns of the Fund for each of the preceding three months – Month 2.
    10.35000000 
    Monthly total returns of the Fund for each of the preceding three months – Month 3.
    6.11000000 
    b. Class identification number(s) (if any) of the Class(es) for which returns are reported.
     

    c. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to derivatives for each of the following categories: commodity contracts, credit contracts, equity contracts, foreign exchange contracts, interest rate contracts, and other contracts. Within each such asset category, further report the same information for each of the following types of derivatives instrument: forward, future, option, swaption, swap, warrant, and other. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.

    Asset category.
    Equity Contracts
    Monthly net realized gain(loss) – Month 1
    297845.17000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    -14560.27000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    156.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    69008.48000000 
    Instrument type.
    Option
    Monthly net realized gain(loss) – Month 1
    297845.17000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    -14560.27000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    156.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    69008.48000000 
    Instrument type.
    Warrant
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Other
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Asset category.
    Other Contracts
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Warrant
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 

    d. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to investment other than derivatives. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.
    Month 1


    Monthly net realized gain(loss) – Month 1
    -1288762.64000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    -35741507.47000000 
    Month 2
    Monthly net realized gain(loss) – Month 2
    -75621.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    55273248.52000000 
    Month 3
    Monthly net realized gain(loss) – Month 3
    -725636.25000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    41248386.41000000 

    Item B.6. Flow information.

    Provide the aggregate dollar amounts for sales and redemptions/repurchases of Fund shares during each of the preceding three months. If shares of the Fund are held in omnibus accounts, for purposes of calculating the Fund's sales, redemptions, and repurchases, use net sales or redemptions/repurchases from such omnibus accounts. The amounts to be reported under this Item should be after any front-end sales load has been deducted and before any deferred or contingent deferred sales load or charge has been deducted. Shares sold shall include shares sold by the Fund to a registered unit investment trust. For mergers and other acquisitions, include in the value of shares sold any transaction in which the Fund acquired the assets of another investment company or of a personal holding company in exchange for its own shares. For liquidations, include in the value of shares redeemed any transaction in which the Fund liquidated all or part of its assets. Exchanges are defined as the redemption or repurchase of shares of one Fund or series and the investment of all or part of the proceeds in shares of another Fund or series in the same family of investment companies.
    Month 1
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    0.00000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 
    Month 2
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    0.00000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 
    Month 3
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    0.00000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 

    Item B.7. Highly Liquid Investment Minimum information.

    a. If applicable, provide the Fund's current Highly Liquid Investment Minimum.
     
    b. If applicable, provide the number of days that the Fund's holdings in Highly Liquid Investments fell below the Fund's Highly Liquid Investment Minimum during the reporting period.
     
    c. Did the Fund's Highly Liquid Investment Minimum change during the reporting period? Yes is not checked Yes No is not checked No N/A is not checked N/A

    Item B.8. Derivatives Transactions.

    For portfolio investments of open-end management investment companies, provide the percentage of the Fund's Highly Liquid Investments that it has pledged as margin or collateral in connection with derivatives transactions that are classified among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]:

    (1) Moderately Liquid Investments
    (2) Less Liquid Investments
    (3) Illiquid Investments

    For purposes of Item B.8, when computing the required percentage, the denominator should only include assets (and exclude liabilities) that are categorized by the Fund as Highly Liquid Investments.

    Classification
     

    Item B.9. Derivatives Exposure for limited derivatives users.

    If the Fund is excepted from the rule 18f-4 [17 CFR 270.18f-4] program requirement and limit on fund leverage risk under rule 18f-4(c)(4) [17 CFR 270.18f-4(c)(4)], provide the following information:

    a. Derivatives exposure (as defined in rule 18f-4(a) [17 CFR 270.18f-4(a)]), reported as a percentage of the Fund’s net asset value.
     
    b. Exposure from currency derivatives that hedge currency risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
     
    c. Exposure from interest rate derivatives that hedge interest rate risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
     
    d. The number of business days, if any, in excess of the five-business-day period described in rule 18f-4(c)(4)(ii) [17 CFR 270.18f-4(c)(4)(ii)], that the Fund’s derivatives exposure exceeded 10 percent of its net assets during the reporting period.
     

    Item B.10. VaR information.

    For Funds subject to the limit on fund leverage risk described in rule 18f-4(c)(2) [17 CFR 270.18f-4(c)(2)], provide the following information, as determined in accordance with the requirement under rule 18f-4(c)(2)(ii) to determine the fund’s compliance with the applicable VaR test at least once each business day:

    a. Median daily VaR during the reporting period, reported as a percentage of the Fund's net asset value.
     
    b. For Funds that were subject to the Relative VaR Test during the reporting period, provide:
    i. As applicable, the name of the Fund’s Designated Index, or a statement that the Fund's Designated Reference Portfolio is the Fund’s Securities Portfolio.
     
    ii. As applicable, the index identifier for the Fund’s Designated Index.
     
    iii. Median VaR Ratio during the reporting period, reported as a percentage of the VaRof the Fund's Designated Reference Portfolio.
     
    c. Backtesting Results. Number of exceptions that the Fund identified as a result of its backtesting of its VaR calculation model (as described in rule 18f-4(c)(1)(iv) [17 CFR 270.18f-4(c)(1)(iv)] during the reporting period.
     

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Charles River Laboratories International Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BSQ0R4UZ5KX287 
    c. Title of the issue or description of the investment.
    Charles River Laboratories International Inc 
    d. CUSIP (if any).
    159864107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1598641074 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    30387.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7183486.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.819220429178 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Global Medical REIT Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300HFRIPQDYU3GU60 
    c. Title of the issue or description of the investment.
    Global Medical REIT Inc 
    d. CUSIP (if any).
    37954A204 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US37954A2042 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    31668.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    351514.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.040087510889 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    RAINIER THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    RAINIER THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943GSBII3 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3728.93000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Omega Healthcare Investors Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300OJ7ENK42CZ8E73 
    c. Title of the issue or description of the investment.
    Omega Healthcare Investors Inc 
    d. CUSIP (if any).
    681936100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US6819361006 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    235358.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7216076.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.822937004225 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ELEVANCE HEALTH INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    8MYN82XMYQH89CTMTH67 
    c. Title of the issue or description of the investment.
    Elevance Health Inc 
    d. CUSIP (if any).
    94973VBJ5 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US94973VBJ52 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    10500000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    10359696.17000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.181442240910 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2024-08-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.50000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    OCULIS HOLDING AG 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    OCULIS HOLDING AG 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    952KVL905 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    83300.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    916300.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.104496841179 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    UNITEDHEALTH GROUP INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012HG5QG0 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -108.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -30564.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00348558491 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    UnitedHealth Group, Inc. 
    Title of issue.
    UnitedHealth Group, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    91324P102 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US91324P1021 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    550.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    5876.28000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    R1 RCM Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    R1 RCM Inc 
    d. CUSIP (if any).
    77634L105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US77634L1052 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    232554.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2458095.78000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.280326578988 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BRISTOL-MYERS SQUIBB CO 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HLYYNH7UQUORYSJQCN42 
    c. Title of the issue or description of the investment.
    Bristol-Myers Squibb Co 
    d. CUSIP (if any).
    110122CN6 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US110122CN68 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7500000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7277091.90000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.829895357987 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2026-06-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.20000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    TENET HEALTHCARE CORP 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG013BGTBN3 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -99.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -9207.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00104998626 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Tenet Healthcare Corp. 
    Title of issue.
    Tenet Healthcare Corp. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    88033G407 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US88033G4073 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    80.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    5346.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Rallybio Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Rallybio Corp 
    d. CUSIP (if any).
    75120L100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US75120L1008 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    594616.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1421132.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.162069005760 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    BOSTON SCIENTIFIC CORP 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01GFVMW85 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -578.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -73406.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00837137959 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Boston Scientific Corp. 
    Title of issue.
    Boston Scientific Corp. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    101137107 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US1011371077 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    57.50000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -50476.74000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Vertex Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    54930015RAQRRZ5ZGJ91 
    c. Title of the issue or description of the investment.
    Vertex Pharmaceuticals Inc 
    d. CUSIP (if any).
    92532F100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US92532F1003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    41552.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    16907093.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.928121620964 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    RESMED INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01GQ9BW57 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -36.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -7560.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00086215881 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    ResMed, Inc. 
    Title of issue.
    ResMed, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    761152107 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US7611521078 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    180.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    3852.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Johnson & Johnson 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300G0CFPGEF6X2043 
    c. Title of the issue or description of the investment.
    Johnson & Johnson 
    d. CUSIP (if any).
    478160104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4781601046 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    402883.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    63147881.42000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    7.201521483769 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    UnitedHealth Group Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GHBMY8T5GXDE41 
    c. Title of the issue or description of the investment.
    UnitedHealth Group Inc 
    d. CUSIP (if any).
    91324P102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91324P1021 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    134051.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    70573829.97000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    8.048392777273 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Pfizer Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    765LHXWGK1KXCLTFYQ30 
    c. Title of the issue or description of the investment.
    Pfizer Inc 
    d. CUSIP (if any).
    717081EC3 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US717081EC37 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3200000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3020152.77000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.344424778287 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2036-12-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.00000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    MEDTRONIC PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012M2JMJ6 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -309.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -12360.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00140956123 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Medtronic PLC 
    Title of issue.
    Medtronic PLC 

    At least one of the following other identifiers:

    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    IE00BTN1Y115 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    85.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    5253.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    BAXTER INTERNATIONAL INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01KNB0Z97 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -95.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -1995.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00022751413 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Baxter International, Inc. 
    Title of issue.
    Baxter International, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    071813109 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US0718131099 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    41.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    760.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Merck & Co Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    4YV9Y5M8S0BRK1RP0397 
    c. Title of the issue or description of the investment.
    Merck & Co Inc 
    d. CUSIP (if any).
    58933YAX3 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58933YAX31 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    4000000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3842460.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.438202557477 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2029-03-07 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.40000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    AGILENT TECHNOLOGIES INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012GP3WH9 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -48.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -5040.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00057477254 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Agilent Technologies, Inc. 
    Title of issue.
    Agilent Technologies, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    00846U101 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US00846U1016 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    145.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    3696.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AbbVie Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FR5LCKFTG8054YNNRU85 
    c. Title of the issue or description of the investment.
    AbbVie Inc 
    d. CUSIP (if any).
    00287YAW9 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00287YAW93 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3080000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2827830.39000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.322491916563 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2046-05-14 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.45000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CIGNA GROUP/THE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300VIWYMSIGT1U456 
    c. Title of the issue or description of the investment.
    Cigna Group/The 
    d. CUSIP (if any).
    125523AH3 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US125523AH38 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1504000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1491884.11000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.170137702609 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-10-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.38000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    DH EUROPE FINANCE II 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    222100KDGL314CKTZ511 
    c. Title of the issue or description of the investment.
    DH Europe Finance II Sarl 
    d. CUSIP (if any).
    23291KAJ4 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US23291KAJ43 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1760000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1459674.57000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.166464456744 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    LUXEMBOURG  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2039-11-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.25000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AbbVie Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FR5LCKFTG8054YNNRU85 
    c. Title of the issue or description of the investment.
    AbbVie Inc 
    d. CUSIP (if any).
    00287Y109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00287Y1091 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    321003.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    49745834.91000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    5.673123005500 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    AVANTOR INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012GRWBR8 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -536.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -8040.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00091689905 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Avantor, Inc. 
    Title of issue.
    Avantor, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    05352A100 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US05352A1007 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    25.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    4824.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Thermo Fisher Scientific Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HCHV7422L5HDJZCRFL38 
    c. Title of the issue or description of the investment.
    Thermo Fisher Scientific Inc 
    d. CUSIP (if any).
    883556102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8835561023 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    73651.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    39093214.29000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    4.458275024407 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    EDWARDS LIFESCIENCES CORP 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012GYTX80 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -260.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -14300.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00163080304 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Edwards Lifesciences 
    Title of issue.
    Edwards Lifesciences 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    28176E108 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US28176E1082 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    80.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    3640.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Agilent Technologies Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    QUIX8Y7A2WP0XRMW7G29 
    c. Title of the issue or description of the investment.
    Agilent Technologies Inc 
    d. CUSIP (if any).
    00846U101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00846U1016 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    49775.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6920218.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.789196712210 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    HUMANA INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01JWZQXY6 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -20.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -8000.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00091233736 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Humana, Inc. 
    Title of issue.
    Humana, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    444859102 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US4448591028 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    475.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    6340.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AMGEN INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    62QBXGPJ34PQ72Z12S66 
    c. Title of the issue or description of the investment.
    Amgen Inc 
    d. CUSIP (if any).
    031162CZ1 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US031162CZ14 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2795000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2291788.42000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.261360526620 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2032-01-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    2.00000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IO LIGHT HOLDINIGS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    IO LIGHT HOLDINIGS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    966MVK907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    189858.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    204249.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.023293026730 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ELEVANCE HEALTH INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    8MYN82XMYQH89CTMTH67 
    c. Title of the issue or description of the investment.
    Elevance Health Inc 
    d. CUSIP (if any).
    036752AG8 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US036752AG89 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2975000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2931379.33000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.334300862473 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-03-01 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.10000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    State Street Global Advisors 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BZ5TGIFZUZDZ37 
    c. Title of the issue or description of the investment.
    State Street Institutional US Government Money Market Fund 
    d. CUSIP (if any).
    857492706 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8574927062 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    39639469.43000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    39639469.43000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    4.520571146429 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle)  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Registered fund  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Universal Health Realty Income Trust 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300L4MWZL4IH6H172 
    c. Title of the issue or description of the investment.
    Universal Health Realty Income Trust 
    d. CUSIP (if any).
    91359E105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91359E1055 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3075.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    132993.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.015166895963 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AbbVie Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FR5LCKFTG8054YNNRU85 
    c. Title of the issue or description of the investment.
    AbbVie Inc 
    d. CUSIP (if any).
    00287YBF5 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00287YBF51 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5303000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5274920.77000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.601563415844 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-11-14 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.25000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IQVIA Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300PLWY28YB00C717 
    c. Title of the issue or description of the investment.
    IQVIA Inc 
    d. CUSIP (if any).
    46266TAA6 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46266TAA60 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1290000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1266064.18000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.144384707563 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2027-05-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    5.00000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AstraZeneca PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    PY6ZZQWO2IZFZC3IOL08 
    c. Title of the issue or description of the investment.
    AstraZeneca PLC 
    d. CUSIP (if any).
    046353AD0 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US046353AD01 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    4750000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5551258.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.633077570470 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2037-09-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    6.45000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Medtronic PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GX3ZBSQWUXY261 
    c. Title of the issue or description of the investment.
    Medtronic PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00BTN1Y115 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    212554.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    17510198.52000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.996901051804 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Zoetis Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300HD9Q1LOC9KLJ48 
    c. Title of the issue or description of the investment.
    Zoetis Inc 
    d. CUSIP (if any).
    98978V103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98978V1035 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    80982.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    15983417.34000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.822783611575 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    LABORATORY CORP OF AMER 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    OZ7UA8IXAIFILY2VZH07 
    c. Title of the issue or description of the investment.
    Laboratory Corp of America Holdings 
    d. CUSIP (if any).
    50540RAQ5 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US50540RAQ56 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2100000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2064037.61000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.235387329827 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2025-02-01 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.60000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Boston Scientific Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    Y6ZDD9FP4P8JSSJMW954 
    c. Title of the issue or description of the investment.
    Boston Scientific Corp 
    d. CUSIP (if any).
    101137107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1011371077 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    397289.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    22967277.09000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.619238138604 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Zimmer Biomet Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    2P2YLDVPES3BXQ1FRB91 
    c. Title of the issue or description of the investment.
    Zimmer Biomet Holdings Inc 
    d. CUSIP (if any).
    98956P102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98956P1021 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    43370.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5278129.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.601929289358 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ResMed Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900T3QE5253CCXF22 
    c. Title of the issue or description of the investment.
    ResMed Inc 
    d. CUSIP (if any).
    761152107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7611521078 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    24600.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4231692.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.482591342186 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Elevance Health Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    8MYN82XMYQH89CTMTH67 
    c. Title of the issue or description of the investment.
    Elevance Health Inc 
    d. CUSIP (if any).
    036752103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0367521038 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    56680.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    26728020.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.048121515425 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Biogen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    W8J5WZB5IY3K0NDQT671 
    c. Title of the issue or description of the investment.
    Biogen Inc 
    d. CUSIP (if any).
    09062X103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09062X1037 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    43552.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    11269951.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.285249682341 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CVS HEALTH CORP 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EJG376EN5NQE29 
    c. Title of the issue or description of the investment.
    CVS Health Corp 
    d. CUSIP (if any).
    126650DQ0 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US126650DQ03 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    4400000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3621051.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.412952544286 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2031-02-28 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    1.88000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Inspire Medical Systems Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300XQQCQ7HCJKTW25 
    c. Title of the issue or description of the investment.
    Inspire Medical Systems Inc 
    d. CUSIP (if any).
    457730109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4577301090 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    24473.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4978542.39000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.567763781986 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    FUSION PHARMACEUTICALS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    FUSION PHARMACEUTICALS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944WZK007 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7160.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    61926.84000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.007062271269 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ZIMMER BIOMET HOLDINGS 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    2P2YLDVPES3BXQ1FRB91 
    c. Title of the issue or description of the investment.
    Zimmer Biomet Holdings Inc 
    d. CUSIP (if any).
    98956PAG7 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98956PAG72 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    6000000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5418840.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.617976277265 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2035-08-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.25000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Stryker Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493002F0SC4JTBU5137 
    c. Title of the issue or description of the investment.
    Stryker Corp 
    d. CUSIP (if any).
    863667AQ4 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US863667AQ47 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3500000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3385013.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.386034262917 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-03-07 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.65000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Physicians Realty Trust 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300ITOVH0OY7PZC34 
    c. Title of the issue or description of the investment.
    Physicians Realty Trust 
    d. CUSIP (if any).
    71943U104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US71943U1043 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    582346.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7751025.26000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.883943747215 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    ABBVIE INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01KN7WY58 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -319.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -36366.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00414725758 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    AbbVie, Inc. 
    Title of issue.
    AbbVie, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    00287Y109 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US00287Y1091 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    157.50000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    10217.57000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Insulet Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300TZTYD2PYN92D43 
    c. Title of the issue or description of the investment.
    Insulet Corp 
    d. CUSIP (if any).
    45784P101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45784P1012 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    21981.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4769437.38000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.543916992703 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Becton Dickinson & Co 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    ICE2EP6D98PQUILVRZ91 
    c. Title of the issue or description of the investment.
    Becton Dickinson & Co 
    d. CUSIP (if any).
    075887109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0758871091 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    16207.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3951752.81000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.450666469243 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    CHARLES RIVER LABORATORIES INT 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01K5N9VN5 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -29.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -13195.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00150478644 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Charles River Laboratories International, Inc. 
    Title of issue.
    Charles River Laboratories International, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    159864107 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US1598641074 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    240.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    2786.32000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    UNITEDHEALTH GROUP INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GHBMY8T5GXDE41 
    c. Title of the issue or description of the investment.
    UnitedHealth Group Inc 
    d. CUSIP (if any).
    91324PEV0 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91324PEV04 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5800000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5763156.54000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.657242882957 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2033-04-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.50000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IQVIA Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300W3R20NM4KQPH86 
    c. Title of the issue or description of the investment.
    IQVIA Holdings Inc 
    d. CUSIP (if any).
    46266C105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46266C1053 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    13712.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3172682.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.361819606663 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Moderna Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EI6OKH5K5Q2G38 
    c. Title of the issue or description of the investment.
    Moderna Inc 
    d. CUSIP (if any).
    60770K107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US60770K1079 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    38588.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3837576.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.437645566392 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Stryker Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493002F0SC4JTBU5137 
    c. Title of the issue or description of the investment.
    Stryker Corp 
    d. CUSIP (if any).
    863667101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8636671013 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    42788.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    12813294.48000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.461255918656 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ELEVANCE HEALTH INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    8MYN82XMYQH89CTMTH67 
    c. Title of the issue or description of the investment.
    Elevance Health Inc 
    d. CUSIP (if any).
    036752AP8 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US036752AP88 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5800000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5035968.55000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.574312785938 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2031-03-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    2.55000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Merck & Co Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    4YV9Y5M8S0BRK1RP0397 
    c. Title of the issue or description of the investment.
    Merck & Co Inc 
    d. CUSIP (if any).
    58933YAR6 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58933YAR62 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2100000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2053336.47000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.234166948591 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2025-02-10 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    2.75000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Diversified Healthcare Trust 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Diversified Healthcare Trust 
    d. CUSIP (if any).
    25525P107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US25525P1075 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    293879.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1099107.46000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.125344600771 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AstraZeneca PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    PY6ZZQWO2IZFZC3IOL08 
    c. Title of the issue or description of the investment.
    AstraZeneca PLC 
    d. CUSIP (if any).
    046353108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0463531089 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    49740.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3349989.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.382040017992 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Cigna Group/The 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    45RS2W538ZOGNWLVIX82 
    c. Title of the issue or description of the investment.
    Cigna Group/The 
    d. CUSIP (if any).
    125523100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1255231003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7700.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2305765.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.262954446144 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CIGNA GROUP/THE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300VIWYMSIGT1U456 
    c. Title of the issue or description of the investment.
    Cigna Group/The 
    d. CUSIP (if any).
    125523CD0 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US125523CD06 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    8250000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    9025620.45000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.029301349679 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2041-11-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    6.13000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CVS Health Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EJG376EN5NQE29 
    c. Title of the issue or description of the investment.
    CVS Health Corp 
    d. CUSIP (if any).
    126650100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1266501006 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    93621.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7392314.16000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.843035554652 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Illumina Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    SQ95QG8SR5Q56LSNF682 
    c. Title of the issue or description of the investment.
    Illumina Inc 
    d. CUSIP (if any).
    452327109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4523271090 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    42604.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5932180.96000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.676518794746 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ELEVANCE HEALTH INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    8MYN82XMYQH89CTMTH67 
    c. Title of the issue or description of the investment.
    Elevance Health Inc 
    d. CUSIP (if any).
    94973VBK2 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US94973VBK26 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2325000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2150211.87000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.245214829512 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2044-08-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.65000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    LivaNova PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    2138001K2FX6SHK2B339 
    c. Title of the issue or description of the investment.
    LivaNova PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    GB00BYMT0J19 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    108480.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5612755.20000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.640090787640 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    LTC Properties Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300NRZP8IJG2KY677 
    c. Title of the issue or description of the investment.
    LTC Properties Inc 
    d. CUSIP (if any).
    502175102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5021751020 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    135390.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4348726.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.495938244847 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ABCURO, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ABCURO, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    902JKGII3 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    601124.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3299990.42000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.376338071388 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CVS Health Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EJG376EN5NQE29 
    c. Title of the issue or description of the investment.
    CVS Health Corp 
    d. CUSIP (if any).
    126650CZ1 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US126650CZ11 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3700000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3460639.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.394658869732 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2048-03-25 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    5.05000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Guardant Health Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900M8C3E5VC8BR186 
    c. Title of the issue or description of the investment.
    Guardant Health Inc 
    d. CUSIP (if any).
    40131M109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US40131M1099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    74536.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2016198.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.229931688082 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Perrigo Co PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300IFOQS6R1QLY196 
    c. Title of the issue or description of the investment.
    Perrigo Co PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00BGH1M568 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    28292.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    910436.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.103828161753 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Incyte Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Z4WN6JVZ3T4680 
    c. Title of the issue or description of the investment.
    Incyte Corp 
    d. CUSIP (if any).
    45337C102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45337C1027 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    30891.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1939645.89000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.221201428038 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sabra Health Care REIT Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300E3BC7GU7TAZ621 
    c. Title of the issue or description of the investment.
    Sabra Health Care REIT Inc 
    d. CUSIP (if any).
    78573L106 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US78573L1061 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    419879.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5991673.33000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.683303433772 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Oculis Holding AG 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5067005370C2KK324336 
    c. Title of the issue or description of the investment.
    Oculis Holding AG 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CH1242303498 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    508459.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5593049.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.637843449812 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    SWITZERLAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intuitive Surgical Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    54930052SRG011710797 
    c. Title of the issue or description of the investment.
    Intuitive Surgical Inc 
    d. CUSIP (if any).
    46120E602 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46120E6023 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    48321.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    16301572.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.859066723541 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    National Health Investors Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300ZPKZIG6DKDEC02 
    c. Title of the issue or description of the investment.
    National Health Investors Inc 
    d. CUSIP (if any).
    63633D104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US63633D1046 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5596.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    312536.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.035642352344 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Amgen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    62QBXGPJ34PQ72Z12S66 
    c. Title of the issue or description of the investment.
    Amgen Inc 
    d. CUSIP (if any).
    031162100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0311621009 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    65086.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    18746069.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.137842486384 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    INSULET CORP 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01DZ0VJ14 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -32.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -25280.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00288298607 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Insulet Corp. 
    Title of issue.
    Insulet Corp. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    45784P101 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US45784P1012 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    220.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    545.60000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CIGNA GROUP/THE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300VIWYMSIGT1U456 
    c. Title of the issue or description of the investment.
    Cigna Group/The 
    d. CUSIP (if any).
    125523BX7 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US125523BX78 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2100000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2079251.48000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.237122352589 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2024-06-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.50000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ENDEAVOR BIOMEDICINES, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ENDEAVOR BIOMEDICINES, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944DTH003 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    742138.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3499997.02000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.399147258243 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Pfizer Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    765LHXWGK1KXCLTFYQ30 
    c. Title of the issue or description of the investment.
    Pfizer Inc 
    d. CUSIP (if any).
    717081ET6 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US717081ET61 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    8100000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7804410.43000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.890031907895 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2029-03-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.45000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Johnson & Johnson 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300G0CFPGEF6X2043 
    c. Title of the issue or description of the investment.
    Johnson & Johnson 
    d. CUSIP (if any).
    478160BV5 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US478160BV55 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    10130000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8862577.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.010707549204 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2046-03-01 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.70000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CVS Health Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EJG376EN5NQE29 
    c. Title of the issue or description of the investment.
    CVS Health Corp 
    d. CUSIP (if any).
    126650CY4 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US126650CY46 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2100000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1989503.12000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.226887254782 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2038-03-25 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.78000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Abbott Laboratories 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HQD377W2YR662HK5JX27 
    c. Title of the issue or description of the investment.
    Abbott Laboratories 
    d. CUSIP (if any).
    002824100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0028241000 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    261502.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    28783525.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.282535692617 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Gilead Sciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300WTZWR07K8MNV44 
    c. Title of the issue or description of the investment.
    Gilead Sciences Inc 
    d. CUSIP (if any).
    375558BM4 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US375558BM47 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    10000000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    9535355.70000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.087432664165 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2027-03-01 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    2.95000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Dexcom Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300YSK3QDSFR5EU59 
    c. Title of the issue or description of the investment.
    Dexcom Inc 
    d. CUSIP (if any).
    252131107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2521311074 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    64154.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7960869.86000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.907874880947 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AbbVie Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FR5LCKFTG8054YNNRU85 
    c. Title of the issue or description of the investment.
    AbbVie Inc 
    d. CUSIP (if any).
    00287YAY5 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00287YAY59 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3245000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3144994.49000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.358661999053 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2026-05-14 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.20000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Johnson & Johnson 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300G0CFPGEF6X2043 
    c. Title of the issue or description of the investment.
    Johnson & Johnson 
    d. CUSIP (if any).
    478160CK8 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US478160CK81 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2200000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2105009.21000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.240059820036 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-01-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    2.90000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    JOHNSON + JOHNSON 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012H362Z0 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -586.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -53912.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00614824151 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Johnson & Johnson 
    Title of issue.
    Johnson & Johnson 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    478160104 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US4781601046 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    160.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    25778.14000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Pfizer Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    765LHXWGK1KXCLTFYQ30 
    c. Title of the issue or description of the investment.
    Pfizer Inc 
    d. CUSIP (if any).
    717081103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7170811035 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    715768.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    20606960.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.350062535799 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Molina Healthcare Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300NQQCEQ46YHZ591 
    c. Title of the issue or description of the investment.
    Molina Healthcare Inc 
    d. CUSIP (if any).
    60855R100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US60855R1005 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    26312.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    9506788.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.084174823750 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sarepta Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300IKDPIED8J8IG21 
    c. Title of the issue or description of the investment.
    Sarepta Therapeutics Inc 
    d. CUSIP (if any).
    803607100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8036071004 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2700.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    260361.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.029692133653 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    ILLUMINA INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG017FP9C41 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -41.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -25010.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00285219469 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Illumina, Inc. 
    Title of issue.
    Illumina, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    452327109 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US4523271090 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    140.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    2784.31000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    UNITEDHEALTH GROUP INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GHBMY8T5GXDE41 
    c. Title of the issue or description of the investment.
    UnitedHealth Group Inc 
    d. CUSIP (if any).
    91324PEJ7 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91324PEJ75 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    10940000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    10705075.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.220830077991 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2032-05-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.20000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Edwards Lifesciences Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    YA13X31F3V31L8TMPR58 
    c. Title of the issue or description of the investment.
    Edwards Lifesciences Corp 
    d. CUSIP (if any).
    28176E108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US28176E1082 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    175447.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    13377833.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.525637202555 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Argenx SE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    7245009C5FZE6G9ODQ71 
    c. Title of the issue or description of the investment.
    Argenx SE 
    d. CUSIP (if any).
    04016X101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US04016X1019 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    12085.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4597496.55000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.524308487186 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    NETHERLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BRISTOL-MYERS SQUIBB CO 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HLYYNH7UQUORYSJQCN42 
    c. Title of the issue or description of the investment.
    Bristol-Myers Squibb Co 
    d. CUSIP (if any).
    110122CP1 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US110122CP17 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2100000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1991771.71000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.227145969710 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2029-07-26 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.40000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Abbott Laboratories 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HQD377W2YR662HK5JX27 
    c. Title of the issue or description of the investment.
    Abbott Laboratories 
    d. CUSIP (if any).
    002824BG4 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US002824BG43 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    10498000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    10752785.62000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.226271015139 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2036-11-30 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.75000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Veradigm Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    Y68YJHVB1GU4TAU3C223 
    c. Title of the issue or description of the investment.
    Veradigm Inc 
    d. CUSIP (if any).
    01988P108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US01988P1084 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    338217.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3547896.33000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.404609799539 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    ABBOTT LABORATORIES 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012GPBZ74 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -302.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -49528.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00564828063 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Abbott Laboratories 
    Title of issue.
    Abbott Laboratories 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    002824100 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US0028241000 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    110.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -12822.92000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    MCKESSON CORP 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG016LQM4C8 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -31.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -31930.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00364136651 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    McKesson Corp. 
    Title of issue.
    McKesson Corp. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    58155Q103 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US58155Q1031 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    460.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -15283.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    IDEXX LABORATORIES INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01G8TJR01 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -27.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -31050.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00354100940 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    IDEXX Laboratories, Inc. 
    Title of issue.
    IDEXX Laboratories, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    45168D104 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US45168D1046 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    560.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -4848.93000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Fusion Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Fusion Pharmaceuticals Inc 
    d. CUSIP (if any).
    36118A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CA36118A1003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    14319.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    137605.59000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.015692840209 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CANADA (FEDERAL LEVEL)  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    I-Mab 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300L1A5T19703RR64 
    c. Title of the issue or description of the investment.
    I-Mab 
    d. CUSIP (if any).
    44975P103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US44975P1030 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    43738.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    83102.20000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.009477155293 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CAYMAN ISLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    THERMO FISHER SCIENTIFIC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HCHV7422L5HDJZCRFL38 
    c. Title of the issue or description of the investment.
    Thermo Fisher Scientific Inc 
    d. CUSIP (if any).
    883556CY6 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US883556CY62 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    6500000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6874804.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.784017599922 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2043-08-10 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    5.40000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Acadia Healthcare Co Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493005CW985Y9D0NC11 
    c. Title of the issue or description of the investment.
    Acadia Healthcare Co Inc 
    d. CUSIP (if any).
    00404A109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00404A1097 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    74939.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5827256.64000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.664552997515 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    GILEAD SCIENCES INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG0149KMS46 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -313.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -27544.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00314117755 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Gilead Sciences, Inc. 
    Title of issue.
    Gilead Sciences, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    375558103 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US3755581036 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    82.50000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -5321.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    ZIMMER BIOMET HOLDINGS INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01K6VS3Z4 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -42.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -5460.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00062267025 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Zimmer Biomet Holdings, Inc. 
    Title of issue.
    Zimmer Biomet Holdings, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    98956P102 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US98956P1021 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    125.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -1512.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Tenet Healthcare Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    0W9AIBT6U6ADJ2I8HK17 
    c. Title of the issue or description of the investment.
    Tenet Healthcare Corp 
    d. CUSIP (if any).
    88033G407 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US88033G4073 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    105224.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7951777.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.906837989002 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CVS Health Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EJG376EN5NQE29 
    c. Title of the issue or description of the investment.
    CVS Health Corp 
    d. CUSIP (if any).
    126650CX6 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US126650CX62 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    789000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    775624.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.088453930280 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-03-25 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    4.30000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    THERMO FISHER SCIENTIFIC INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012HF3B86 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -73.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -61320.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00699306591 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Thermo Fisher Scientific, Inc. 
    Title of issue.
    Thermo Fisher Scientific, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    883556102 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US8835561023 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    540.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    11412.09000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HCA Healthcare Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900PH4ZGUH2MNEU89 
    c. Title of the issue or description of the investment.
    HCA Healthcare Inc 
    d. CUSIP (if any).
    40412C101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US40412C1018 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    27081.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7330285.08000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.835961623711 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Avantor Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Avantor Inc 
    d. CUSIP (if any).
    05352A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US05352A1007 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    372520.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8504631.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.969886650220 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    McKesson Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300WZWOM80UCFSF54 
    c. Title of the issue or description of the investment.
    McKesson Corp 
    d. CUSIP (if any).
    58155Q103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58155Q1031 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    31638.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    14647761.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.670462490378 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Humana Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900YLDW34GJAO4J06 
    c. Title of the issue or description of the investment.
    Humana Inc 
    d. CUSIP (if any).
    444859102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4448591028 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    41447.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    18974851.07000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.163933208195 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Danaher Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    S4BKK9OTCEWQ3YHPFM11 
    c. Title of the issue or description of the investment.
    Danaher Corp 
    d. CUSIP (if any).
    235851102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2358511028 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    112281.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    25975086.54000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.962255257883 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Regeneron Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300RCBFWIRX3HYQ56 
    c. Title of the issue or description of the investment.
    Regeneron Pharmaceuticals Inc 
    d. CUSIP (if any).
    75886F107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US75886F1075 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    24293.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    21336298.97000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.433237853137 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    INCYTE CORP 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01K61P3D7 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -45.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -3510.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00040028801 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Incyte Corp. 
    Title of issue.
    Incyte Corp. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    45337C102 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US45337C1027 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    65.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -630.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Medical Properties Trust Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900U6E39J1MQCCY14 
    c. Title of the issue or description of the investment.
    Medical Properties Trust Inc 
    d. CUSIP (if any).
    58463J304 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58463J3041 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    266557.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1308794.87000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.149257808214 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    DANAHER CORP 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01KNF6ZG4 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -166.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -70550.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00804567515 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Danaher Corp. 
    Title of issue.
    Danaher Corp. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    235851102 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US2358511028 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    235.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -11288.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Community Health Systems Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Community Health Systems Inc 
    d. CUSIP (if any).
    203668108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2036681086 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    79635.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    249257.55000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.028425872110 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    UnitedHealth Group Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GHBMY8T5GXDE41 
    c. Title of the issue or description of the investment.
    UnitedHealth Group Inc 
    d. CUSIP (if any).
    91324PDP4 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91324PDP45 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    4970000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4864624.52000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.554772340789 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-12-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.88000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    VERTEX PHARMACEUTICALS INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01KNW1DQ0 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -40.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -6000.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00068425302 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Vertex Pharmaceuticals, Inc. 
    Title of issue.
    Vertex Pharmaceuticals, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    92532F100 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US92532F1003 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    425.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    6680.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Teva Pharmaceutical Industries Ltd 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BAFGM4RC74ZJ94 
    c. Title of the issue or description of the investment.
    Teva Pharmaceutical Industries Ltd 
    d. CUSIP (if any).
    881624209 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8816242098 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    77704.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    811229.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.092514402914 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    ISRAEL  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Healthcare Realty Trust Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300L0I14L7I0VLX84 
    c. Title of the issue or description of the investment.
    Healthcare Realty Trust Inc 
    d. CUSIP (if any).
    42226K105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US42226K1051 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    25119.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    432800.37000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.049357493753 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Merck & Co Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    4YV9Y5M8S0BRK1RP0397 
    c. Title of the issue or description of the investment.
    Merck & Co Inc 
    d. CUSIP (if any).
    58933Y105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58933Y1055 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    504200.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    54967884.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    6.268656820179 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    CATALENT INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01F3TMFC7 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -46.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -8464.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00096525293 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Catalent, Inc. 
    Title of issue.
    Catalent, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    148806102 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US1488061029 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    45.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    1434.74000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Healthpeak Properties Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900M6MTMZM0I22L81 
    c. Title of the issue or description of the investment.
    Healthpeak Properties Inc 
    d. CUSIP (if any).
    42250P103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US42250P1030 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    66791.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1322461.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.150816414581 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    REIT 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    DEXCOM INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG012GY2HH4 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -92.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -23000.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00262296993 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Dexcom, Inc. 
    Title of issue.
    Dexcom, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    252131107 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US2521311074 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    130.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    4325.84000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    MOLINA HEALTHCARE INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01HG4HRR8 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -25.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -4150.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.00047327500 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Molina Healthcare, Inc. 
    Title of issue.
    Molina Healthcare, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    60855R100 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US60855R1005 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    380.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    7025.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    STERIS PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    STERIS PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00BFY8C754 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    21172.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4654664.20000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.530828010097 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    West Pharmaceutical Services Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493007NKRGM1RJQ1P16 
    c. Title of the issue or description of the investment.
    West Pharmaceutical Services Inc 
    d. CUSIP (if any).
    955306105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US9553061055 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    6192.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2180327.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.248649228875 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Eli Lilly & Co 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FRDRIPF3EKNDJ2CQJL29 
    c. Title of the issue or description of the investment.
    Eli Lilly & Co 
    d. CUSIP (if any).
    532457108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5324571083 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    136846.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    79770270.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    9.097174799179 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Galera Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Galera Therapeutics Inc 
    d. CUSIP (if any).
    36338D108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US36338D1081 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    314430.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    45718.12000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.005213793653 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CIGNA GROUP/THE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300VIWYMSIGT1U456 
    c. Title of the issue or description of the investment.
    Cigna Group/The 
    d. CUSIP (if any).
    125523CM0 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US125523CM05 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5800000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4957233.61000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.565333682456 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2031-03-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    2.38000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BECTON DICKINSON & CO 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    ICE2EP6D98PQUILVRZ91 
    c. Title of the issue or description of the investment.
    Becton Dickinson & Co 
    d. CUSIP (if any).
    075887BW8 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US075887BW84 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2413000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2338308.46000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.266665772971 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2027-06-06 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.70000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Catalent Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Catalent Inc 
    d. CUSIP (if any).
    148806102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1488061029 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    48600.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2183598.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.249022256254 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IDEXX Laboratories Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    OGMTXK0LUU1HKV2P0J84 
    c. Title of the issue or description of the investment.
    IDEXX Laboratories Inc 
    d. CUSIP (if any).
    45168D104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45168D1046 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    18387.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    10205704.35000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.163880679459 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Amgen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    62QBXGPJ34PQ72Z12S66 
    c. Title of the issue or description of the investment.
    Amgen Inc 
    d. CUSIP (if any).
    031162CQ1 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US031162CQ15 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2200000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2101618.51000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.239673137247 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2027-11-02 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.20000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Baxter International Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    J5OIVXX3P24RJRW5CK77 
    c. Title of the issue or description of the investment.
    Baxter International Inc 
    d. CUSIP (if any).
    071813109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0718131099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    198244.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7664113.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.874032088970 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Bristol-Myers Squibb Co 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HLYYNH7UQUORYSJQCN42 
    c. Title of the issue or description of the investment.
    Bristol-Myers Squibb Co 
    d. CUSIP (if any).
    110122108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1101221083 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    276824.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    14203839.44000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.619836684604 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    UnitedHealth Group Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300GHBMY8T5GXDE41 
    c. Title of the issue or description of the investment.
    UnitedHealth Group Inc 
    d. CUSIP (if any).
    91324PDK5 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91324PDK57 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1460000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1427585.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.162804983753 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2028-06-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    3.85000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Options Clearing Corp. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CII6SLYGKNHA04 
    c. Title of the issue or description of the investment.
    ELI LILLY + CO 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    BBG01GJHQFY6 
    Description of other unique identifier.
    Bloomberg Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    -186.00000000 
    Units
    Number of contracts  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    -89280.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    -0.01018168501 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Option  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    Options Clearing Corp. 
    LEI (if any) of counterparty.
    549300CII6SLYGKNHA04 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is checked Written Purchased is not checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Eli Lilly & Co. 
    Title of issue.
    Eli Lilly & Co. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    532457108 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US5324571083 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    100.00000000 
    v. Exercise price or rate.
    610.00000000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2024-01-19 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    58614.18000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Gilead Sciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300WTZWR07K8MNV44 
    c. Title of the issue or description of the investment.
    Gilead Sciences Inc 
    d. CUSIP (if any).
    375558103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US3755581036 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    214756.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    17397383.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.984035388858 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part E: Explanatory Notes (if any)

    The Fund may provide any information it believes would be helpful in understanding the information reported in response to any Item of this Form. The Fund may also explain any assumptions that it made in responding to any Item of this Form. To the extent responses relate to a particular Item, provide the Item number(s), as applicable.
    Note Item
    B.5.a 
    Explanatory Notes
    Monthly returns presented in Item B.5(a) have been calculated without deducting any applicable sales loads or redemption fees. 

    NPORT-P: Signatures

    The Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Registrant:
    abrdn Healthcare Opportunities Fund 
    By(Signature):
    Sharon Ferrari 
    Name:
    Sharon Ferrari 
    Title:
    Assistant Treasurer 
    Date:
    2024-01-31 

    Documents

    Get the next $THQ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $THQ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $THQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Dimartino Rose bought $21,300 worth of shares (1,000 units at $21.30) (SEC Form 4)

      4 - abrdn Healthcare Opportunities Fund (0001604522) (Issuer)

      7/18/24 2:57:22 PM ET
      $THQ
      Finance Companies
      Finance
    • Goetz Kathleen bought $11,723 worth of shares (600 units at $19.54), increasing direct ownership by 109% to 1,148 units (SEC Form 4)

      4 - abrdn Healthcare Opportunities Fund (0001604522) (Issuer)

      4/12/24 9:21:22 AM ET
      $THQ
      Finance Companies
      Finance
    • Reit Todd bought $18,436 worth of shares (1,000 units at $18.44) (SEC Form 4)

      4 - abrdn Healthcare Opportunities Fund (0001604522) (Issuer)

      1/4/24 2:23:56 PM ET
      $THQ
      Finance Companies
      Finance

    $THQ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / November 29, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:THQ), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on November 29, 2024, on a per share basis to all shareholders of record as of November 21, 2024 (ex-dividend date November 21, 2024).TickerExchangeFundAmountASGINYSEabrdn Global Infrastructure Income Fund$0.2100THQNYSEabrdn Healthcare Opportunities Fund$0.1800Each Fund has adopted a distribution policy to provide investors with a stable distribution out of current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital.Under appli

      11/29/24 4:17:00 PM ET
      $ASGI
      $AWP
      $THQ
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / November 1, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:THQ), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on October 31, 2024, on a per share basis to all shareholders of record as of October 24, 2024 (ex-dividend date October 24, 2024).TickerExchangeFundAmountASGINYSEabrdn Global Infrastructure Income Fund$0.2100THQNYSEabrdn Healthcare Opportunities Fund$0.1800Each Fund has adopted a distribution policy to provide investors with a stable distribution out of current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital.Under applicabl

      11/1/24 4:27:00 PM ET
      $ASGI
      $AWP
      $THQ
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 30, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:THQ)(NYSE:THW), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on August 30, 2024, on a per share basis to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024).TickerExchangeFundAmountASGINYSEabrdn Global Infrastructure Income Fund$0.2000THQNYSEabrdn Healthcare Opportunities Fund$0.1800THWNYSEabrdn World Healthcare Fund$0.1167Each Fund has adopted a distribution policy to provide investors with a stable distribution out of current income, supplemented by realized capital gains and, to the ex

      8/30/24 4:27:00 PM ET
      $ASGI
      $THQ
      $THW
      Investment Managers
      Finance
      Finance Companies

    $THQ
    SEC Filings

    See more
    • SEC Form N-CEN filed by abrdn Healthcare Opportunities Fund Shares of Beneficial Inter

      N-CEN - abrdn Healthcare Opportunities Fund (0001604522) (Filer)

      12/16/24 11:48:22 AM ET
      $THQ
      Finance Companies
      Finance
    • SEC Form N-CSR filed by abrdn Healthcare Opportunities Fund Shares of Beneficial Inter

      N-CSR - abrdn Healthcare Opportunities Fund (0001604522) (Filer)

      12/9/24 12:52:56 PM ET
      $THQ
      Finance Companies
      Finance
    • SEC Form N-PX filed by abrdn Healthcare Opportunities Fund Shares of Beneficial Inter

      N-PX - abrdn Healthcare Opportunities Fund (0001604522) (Filer)

      8/30/24 5:37:00 PM ET
      $THQ
      Finance Companies
      Finance

    $THQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Hepp Robert W.

      3 - abrdn Healthcare Opportunities Fund (0001604522) (Issuer)

      3/20/25 4:38:07 PM ET
      $THQ
      Finance Companies
      Finance
    • SEC Form 3 filed by new insider Gebauer Katie Lynn

      3 - abrdn Healthcare Opportunities Fund (0001604522) (Issuer)

      3/20/25 4:34:16 PM ET
      $THQ
      Finance Companies
      Finance
    • SEC Form 3 filed by new insider Hasson Heather

      3 - abrdn Healthcare Opportunities Fund (0001604522) (Issuer)

      3/20/25 4:29:23 PM ET
      $THQ
      Finance Companies
      Finance

    $THQ
    Financials

    Live finance-specific insights

    See more
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / November 29, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:THQ), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on November 29, 2024, on a per share basis to all shareholders of record as of November 21, 2024 (ex-dividend date November 21, 2024).TickerExchangeFundAmountASGINYSEabrdn Global Infrastructure Income Fund$0.2100THQNYSEabrdn Healthcare Opportunities Fund$0.1800Each Fund has adopted a distribution policy to provide investors with a stable distribution out of current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital.Under appli

      11/29/24 4:17:00 PM ET
      $ASGI
      $AWP
      $THQ
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / November 1, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:THQ), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on October 31, 2024, on a per share basis to all shareholders of record as of October 24, 2024 (ex-dividend date October 24, 2024).TickerExchangeFundAmountASGINYSEabrdn Global Infrastructure Income Fund$0.2100THQNYSEabrdn Healthcare Opportunities Fund$0.1800Each Fund has adopted a distribution policy to provide investors with a stable distribution out of current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital.Under applicabl

      11/1/24 4:27:00 PM ET
      $ASGI
      $AWP
      $THQ
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 30, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:THQ)(NYSE:THW), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on August 30, 2024, on a per share basis to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024).TickerExchangeFundAmountASGINYSEabrdn Global Infrastructure Income Fund$0.2000THQNYSEabrdn Healthcare Opportunities Fund$0.1800THWNYSEabrdn World Healthcare Fund$0.1167Each Fund has adopted a distribution policy to provide investors with a stable distribution out of current income, supplemented by realized capital gains and, to the ex

      8/30/24 4:27:00 PM ET
      $ASGI
      $THQ
      $THW
      Investment Managers
      Finance
      Finance Companies

    $THQ
    Leadership Updates

    Live Leadership Updates

    See more
    • abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

      PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has

      3/21/24 7:59:00 AM ET
      $AWP
      $HQH
      $HQL
      $THQ
      Trusts Except Educational Religious and Charitable
      Finance
      Finance Companies
      Investment Managers